Photograph of Robbie Rogart Jost

Robbie Rogart Jost

Counsel


Robbie Rogart Jost is a counsel in the Mass Tort, Product, and Consumer Litigation, Product Risk Management, and Litigation groups in Crowell & Moring's Washington, D.C. office. Robbie represents clients across numerous industries in a diverse array of commercial, class action, multi-district, health care, and products liability litigations in state and federal courts. Robbie also provides counseling regarding product liability, risk management, and consumer product regulatory compliance, with a focus on health care and medical devices.

In addition, Robbie has an active pro bono practice, including recent work on a child custody case, a special education matter in D.C. Public Schools, defense of a public housing tenant in an eviction proceeding by D.C.H.A. for nonpayment of rent, and research regarding potential Fourth Amendment implications of searches in the homes of public housing tenants.

During law school, Robbie interned for the Honorable Marian Blank Horn on the U.S. Court of Federal Claims and served as an articles editor on the Journal of Law & Politics. Before joining Crowell & Moring, Robbie clerked for the Honorable John F. Anderson on the U.S. District Court for the Eastern District of Virginia in Alexandria, Virginia.

Education

  • University of Virginia, B.A. political philosophy, policy & law (2009) high honors
  • University of Virginia School of Law, J.D. (2012)

Affiliations

Admitted to practice: District of Columbia, Virginia

View More

Practices

Litigation & Trial

Mass Tort, Product, and Consumer Litigation

Commercial Litigation

Product Risk Management

Show more practices…

  • Defending an international medical device manufacturer in all U.S. product liability litigation.
  • Defending a health care services and products company in U.S. product liability litigation related to medical devices.
  • Defending an international medical device manufacturer in product liability litigation in the United States, including issues related to the Federal Food, Drug and Cosmetic Act and the Premarket Approval (PMA) process.
  • Defending Blue Cross and Blue Shield companies in Multidistrict Litigation (MDL) national and statewide class actions asserting antitrust claims.
  • Defended an insurance risk retention group in settlement of numerous class action lawsuits.
  • Negotiated and supported “limited fund” settlement of hundreds of class action lawsuits against a university following its loss of accreditation.
  • Defended a major retailer against a potential civil penalty enforcement action for alleged late reporting regarding a product recall.
  • Defended a product manufacturer in MDL national class actions asserting claims under the Telephone Consumer Protection Act.
"3D Printing at the Point of Care: Compliance and Liability Concerns," Orange County Bar Association, 2022 (November 10, 2022). Speakers: John Fuson, Hilary Johnson, Andrew McElligott, Robbie Jost.
Speech/Presentation
"3D Printing at the Point of Care: Compliance and Liability Concerns," Orange County Bar Association Health Care Law Section Webinar, 2022. (November 10, 2022). Speakers: John Fuson, Hilary Johnson, Robbie Rogart Jost, and Andew McElligott.
Speech/Presentation
"FDA Issues Final Guidance on Clinical Decision Support Software," Mass Tort, Product, and Consumer Litigation Alert (October 10, 2022). Contacts: Jodi G. Daniel, Tara Singh, John Fuson, Robbie Rogart Jost, Rachael Padgett, Lidia Niecko-Najjum
Client Alert / Newsletter
"10 Ways to Reduce Cyberattack Risks on Internet-Connected Medical Devices," Mass Tort, Product, and Consumer Litigation Alert (September 24, 2021). Contacts: Andrew D. Kaplan, Robbie Rogart Jost, Mimi S. Dennis
Client Alert / Newsletter
"Proposed Legislation Would Expand FDA Authority Over Counterfeit Medical Devices," Mass Tort, Product, and Consumer Litigation Alert (October 2, 2020). Contacts: Andrew D. Kaplan, Hilary Johnson, Robbie Rogart Jost
Client Alert / Newsletter
Crowell & Moring And Thomson Reuters Team Up To Develop Westlaw Edge Quick Check's Future Thomson Reuters Legal Current (August 15, 2019)
Press Coverage
"Supreme Court Decision Raises New Questions on Impossibility Preemption in Cases Challenging Sufficiency of Drug Label Warnings," Mass Tort, Product, and Consumer Litigation Alert (June 7, 2019). Contacts: John Fuson, Andrew D. Kaplan, Robbie Rogart Jost
Client Alert / Newsletter
Crowell & Moring Elects Seven New Partners and Promotes 23 Associates to Counsel (January 4, 2018)
Firm News / Announcement
"FDA Issues First-of-Its-Kind Guidance for Manufacturers of 3D-Printed Medical Devices," Crowell & Moring's Recent Happenings in Advertising & Product Risk Management – December 2017 (December 20, 2017). Authors: Rebecca Baden Chaney, Robbie Rogart, and Chalana Netasha Damron.
Publication
"Recent Happenings in Advertising & Product Risk Management – December 2017," Advertising & State AG Alert (December 20, 2017). Contacts: Cheryl A. Falvey, John Fuson, David Ervin, Matthew Cohen, Rebecca Baden Chaney, Robbie Rogart Jost, Kate M. Watkins, Rukiya Mohamed
Client Alert / Newsletter

For all Highlights, News & Knowledge, please click here to view desktop bio.

Crowell & Moring LLP is an international law firm with offices in the United States, Europe, MENA, and Asia that represents clients in litigation and arbitration, regulatory and policy, and transactional and corporate matters. The firm is internationally recognized for its representation of Fortune 500 companies in high-stakes litigation and government-facing matters, as well as its ongoing commitment to pro bono service and diversity, equity, and inclusion.

View Desktop Site | Mobile Sitemap |

Contact | Subscribe | Terms of Use | Privacy Statement | Alumni

© Crowell & Moring LLP 2022
Attorney advertising - prior results do not guarantee a similar outcome.